Free Trial

Texas Instruments (TXN) Financials

Texas Instruments logo
$183.24 +6.94 (+3.94%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$183.75 +0.51 (+0.28%)
As of 05/27/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Texas Instruments

Annual Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
4,775 6,477 8,710 7,736 5,568 4,986 5,538 3,649 3,551 2,944
Consolidated Net Income / (Loss)
4,799 6,510 8,749 7,769 5,595 5,017 5,580 3,682 3,595 2,986
Net Income / (Loss) Continuing Operations
4,799 6,510 8,749 7,769 5,595 5,017 5,580 3,682 3,595 2,986
Total Pre-Tax Income
5,453 7,418 10,032 8,919 6,017 5,728 6,686 6,080 4,930 4,216
Total Operating Income
5,465 7,331 10,140 8,960 5,894 5,723 6,713 6,083 4,855 4,322
Total Gross Profit
9,094 11,019 13,771 12,376 9,269 9,164 10,277 9,614 8,257 7,575
Total Revenue
15,641 17,519 20,028 18,344 14,461 14,383 15,784 14,961 13,370 13,000
Operating Revenue
15,641 17,519 20,028 18,344 14,461 14,383 15,784 14,961 13,370 13,000
Total Cost of Revenue
6,547 6,500 6,257 5,968 5,192 5,219 5,507 5,347 5,113 5,425
Operating Cost of Revenue
6,547 6,500 6,257 5,968 5,192 5,219 5,507 5,347 5,113 5,425
Total Operating Expenses
3,629 3,688 3,631 3,416 3,375 3,441 3,564 3,531 3,402 3,253
Selling, General & Admin Expense
1,794 1,825 1,704 1,720 1,647 1,645 1,684 1,694 1,742 1,728
Research & Development Expense
1,959 1,863 1,670 1,554 1,530 1,544 1,559 1,508 1,356 1,267
Restructuring Charge
-124 0.00 257 - - -36 321 329 304 258
Total Other Income / (Expense), net
-12 87 -108 -41 123 5.00 -27 -3.00 75 -106
Interest Expense
508 353 214 184 190 170 125 78 80 90
Other Income / (Expense), net
496 440 106 143 313 175 98 75 155 -16
Income Tax Expense
654 908 1,283 1,150 422 711 1,106 2,398 1,335 1,230
Preferred Stock Dividends Declared
24 33 39 33 27 31 42 33 44 42
Basic Earnings per Share
$5.24 $7.13 $9.51 $8.38 $6.05 $5.33 $5.71 $3.68 $3.54 $2.86
Weighted Average Basic Shares Outstanding
912M 908M 916M 923M 921M 936M 970M 991M 1.00B 1.03B
Diluted Earnings per Share
$5.20 $7.07 $9.41 $8.26 $5.97 $5.24 $5.59 $3.61 $3.48 $2.82
Weighted Average Diluted Shares Outstanding
919M 916M 926M 936M 933M 952M 990M 1.01B 1.02B 1.04B
Weighted Average Basic & Diluted Shares Outstanding
910.33M 909.29M 906.21M 923.55M 920.24M 933.98M 969.90M 991.60M 1.00B 1.03B
Cash Dividends to Common per Share
$5.26 $5.02 $4.69 $4.21 $3.72 $3.21 $2.63 $2.12 $1.64 $1.40

Quarterly Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
1,173 1,199 1,355 1,121 1,100 1,365 1,699 1,714 1,699 1,953 2,284
Consolidated Net Income / (Loss)
1,179 1,205 1,362 1,127 1,105 1,371 1,709 1,722 1,708 1,962 2,295
Net Income / (Loss) Continuing Operations
1,179 1,205 1,362 1,127 1,105 1,371 1,709 1,722 1,708 1,962 2,295
Total Pre-Tax Income
1,276 1,359 1,554 1,247 1,293 1,548 1,922 2,002 1,946 2,167 2,658
Total Operating Income
1,324 1,377 1,554 1,248 1,286 1,533 1,892 1,972 1,934 2,176 2,678
Total Gross Profit
2,313 2,314 2,474 2,211 2,095 2,431 2,815 2,910 2,863 3,087 3,617
Total Revenue
4,069 4,007 4,151 3,822 3,661 4,077 4,532 4,531 4,379 4,670 5,241
Operating Revenue
4,069 4,007 4,151 3,822 3,661 4,077 4,532 4,531 4,379 4,670 5,241
Total Cost of Revenue
1,756 1,693 1,677 1,611 1,566 1,646 1,717 1,621 1,516 1,583 1,624
Operating Cost of Revenue
1,756 1,693 1,677 1,611 1,566 1,646 1,717 1,621 1,516 1,583 1,624
Total Operating Expenses
989 937 920 963 809 898 923 938 929 911 939
Selling, General & Admin Expense
472 446 428 465 455 438 452 461 474 220 508
Research & Development Expense
517 491 492 498 478 460 471 477 455 434 431
Restructuring Charge
0.00 - 0.00 0.00 -124 - 0.00 0.00 - - -
Total Other Income / (Expense), net
-48 -18 0.00 -1.00 7.00 15 30 30 12 -9.00 -20
Interest Expense
128 130 131 131 116 98 98 89 68 60 53
Other Income / (Expense), net
80 112 131 130 123 113 128 119 80 51 33
Income Tax Expense
97 154 192 120 188 177 213 280 238 205 363
Preferred Stock Dividends Declared
6.00 6.00 7.00 6.00 5.00 6.00 10 8.00 9.00 9.00 11
Basic Earnings per Share
$1.29 $1.32 $1.48 $1.23 $1.21 $1.50 $1.87 $1.89 $1.87 $2.16 $2.50
Weighted Average Basic Shares Outstanding
910M 912M 913M 912M 910M 908M 908M 908M 907M 916M 913M
Diluted Earnings per Share
$1.28 $1.31 $1.47 $1.22 $1.20 $1.50 $1.85 $1.87 $1.85 $2.14 $2.47
Weighted Average Diluted Shares Outstanding
916M 919M 920M 919M 917M 916M 916M 916M 916M 926M 923M
Weighted Average Basic & Diluted Shares Outstanding
908.47M 910.33M 912.22M 913.05M 910.48M 909.29M 908.20M 907.97M 907.65M 906.21M 907.57M
Cash Dividends to Common per Share
$1.36 - $1.30 $1.30 $1.30 - $1.24 $1.24 $1.24 - $1.15

Annual Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
236 -86 -1,581 1,524 670 -1.00 782 502 154 -199
Net Cash From Operating Activities
6,318 6,420 8,720 8,756 6,139 6,649 7,189 5,363 4,614 4,397
Net Cash From Continuing Operating Activities
6,318 6,420 8,720 8,756 6,139 6,649 7,189 5,366 4,614 4,397
Net Income / (Loss) Continuing Operations
4,799 6,510 8,749 7,769 5,595 5,017 5,580 3,682 3,595 2,986
Consolidated Net Income / (Loss)
4,799 6,510 8,749 7,769 5,595 5,017 5,580 3,682 3,595 2,986
Depreciation Expense
1,508 1,175 925 755 733 708 590 539 605 766
Amortization Expense
72 63 54 199 259 342 364 365 350 367
Non-Cash Adjustments To Reconcile Net Income
260 362 286 173 220 194 229 242 212 201
Changes in Operating Assets and Liabilities, net
-321 -1,690 -1,294 -140 -668 388 426 538 -148 77
Net Cash From Investing Activities
-3,202 -4,362 -3,583 -4,095 -922 -1,920 -78 -1,127 -650 -302
Net Cash From Continuing Investing Activities
-3,202 -4,362 -3,583 -4,095 -922 -1,920 -78 -1,127 -650 -302
Purchase of Property, Plant & Equipment
-4,820 -5,071 -2,797 -2,462 -649 -847 -1,131 -695 -531 -551
Purchase of Investments
-9,716 -12,705 -14,483 -10,124 -5,786 -3,444 -5,641 -4,555 -3,503 -2,767
Sale of Property, Plant & Equipment
195 3.00 3.00 75 4.00 30 9.00 40 0.00 110
Sale and/or Maturity of Investments
11,187 13,387 13,657 8,478 5,545 2,309 6,708 4,095 3,390 2,892
Other Investing Activities, net
-48 24 37 -62 -36 32 -23 -12 -6.00 14
Net Cash From Financing Activities
-2,880 -2,144 -6,718 -3,137 -4,547 -4,730 -6,329 -3,734 -3,810 -4,294
Net Cash From Continuing Financing Activities
-2,880 -2,144 -6,718 -3,137 -4,547 -4,730 -6,329 -3,734 -3,810 -4,294
Repayment of Debt
-653 -557 -541 -596 -536 -792 -547 -656 -1,003 -1,003
Repurchase of Common Equity
-929 -293 -3,615 -527 -2,553 -2,960 -5,100 -2,556 -2,132 -2,741
Payment of Dividends
-4,795 -4,557 -4,297 -3,886 -3,426 -3,008 -2,555 -2,104 -1,646 -1,444
Issuance of Debt
2,980 3,000 1,494 1,495 1,498 1,491 1,500 1,099 499 498
Issuance of Common Equity
517 263 241 377 470 539 373 483 472 396

Quarterly Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-437 611 -151 257 -481 398 -873 -1,038 1,427 -119 -633
Net Cash From Operating Activities
849 1,998 1,732 1,571 1,017 1,924 1,937 1,399 1,160 2,042 2,766
Net Cash From Continuing Operating Activities
849 1,998 1,732 1,571 1,017 1,924 1,937 1,399 1,160 2,042 2,766
Net Income / (Loss) Continuing Operations
1,179 1,205 1,362 1,127 1,105 1,371 1,709 1,722 1,708 1,962 2,295
Consolidated Net Income / (Loss)
1,179 1,205 1,362 1,127 1,105 1,371 1,709 1,722 1,708 1,962 2,295
Depreciation Expense
424 416 383 363 346 322 303 285 265 249 249
Amortization Expense
20 19 19 18 16 15 17 15 16 14 13
Non-Cash Adjustments To Reconcile Net Income
116 77 87 119 -23 69 79 110 104 62 68
Changes in Operating Assets and Liabilities, net
-890 281 -119 -56 -427 147 -171 -733 -933 -245 141
Net Cash From Investing Activities
1,253 614 -487 - -3,329 -311 -1,694 -2,385 28 -1,027 -2,113
Net Cash From Continuing Investing Activities
1,253 614 -487 - -3,329 -311 -1,694 -2,385 28 -1,027 -2,113
Purchase of Property, Plant & Equipment
-1,123 -1,192 -1,316 -1,064 -1,248 -1,148 -1,495 -1,446 -982 -967 -790
Purchase of Investments
-647 -909 -1,845 -2,098 -4,864 -2,565 -3,080 -4,047 -3,013 -3,688 -4,346
Sale of Property, Plant & Equipment
0.00 1.00 - 2.00 192 - 1.00 1.00 1.00 - -
Sale and/or Maturity of Investments
2,807 2,726 2,700 3,130 2,631 3,411 2,885 3,065 4,026 3,650 3,033
Other Investing Activities, net
216 -12 -26 30 -40 -9.00 -5.00 42 -4.00 -22 -10
Net Cash From Financing Activities
-2,539 -2,001 -1,396 -1,314 1,831 -1,215 -1,116 -52 239 -1,134 -1,286
Net Cash From Continuing Financing Activities
-2,539 -2,001 -1,396 -1,314 1,831 -1,215 -1,116 -52 239 -1,134 -1,286
Repayment of Debt
-766 -311 -8.00 -306 -28 -14 -12 -516 -15 -12 -12
Repurchase of Common Equity
-653 -537 -318 -71 -3.00 -65 -46 -79 -103 -848 -996
Payment of Dividends
-1,238 -1,240 -1,187 -1,185 -1,183 -1,181 -1,126 -1,125 -1,125 -1,123 -1,051
Issuance of Debt
0.00 - - - 2,980 - - 1,603 1,397 799 695
Issuance of Common Equity
118 87 117 248 65 45 68 65 85 50 78

Annual Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
35,509 32,348 27,207 24,676 19,351 18,018 17,137 17,642 16,431 16,230
Total Current Assets
15,026 15,122 14,021 13,685 10,239 8,761 8,097 8,734 7,457 7,074
Cash & Equivalents
3,200 2,964 3,050 4,631 3,107 2,437 2,438 1,656 1,154 1,000
Short-Term Investments
4,380 5,611 6,017 5,108 3,461 2,950 1,795 2,813 2,336 2,218
Accounts Receivable
1,719 1,787 1,895 1,701 1,414 1,074 1,207 1,278 1,267 1,165
Inventories, net
4,527 3,999 2,757 1,910 1,955 2,001 2,217 1,957 1,790 1,691
Prepaid Expenses
1,200 761 302 335 302 299 440 1,030 910 1,000
Plant, Property, & Equipment, net
11,347 9,999 6,876 5,141 3,269 3,303 3,183 2,664 2,512 2,596
Plant, Property & Equipment, gross
15,254 13,268 9,950 7,858 5,781 5,740 5,425 4,789 4,923 5,465
Accumulated Depreciation
3,907 3,269 3,074 2,717 2,512 2,437 2,242 2,125 2,411 2,869
Total Noncurrent Assets
9,136 7,227 6,310 5,850 5,843 5,954 5,857 6,244 6,462 6,560
Goodwill
4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362
Intangible Assets
257 223 152 85 122 409 717 1,056 1,316 1,629
Noncurrent Deferred & Refundable Income Taxes
936 757 473 263 343 197 295 264 374 201
Employee Benefit Assets
233 173 188 392 246 218 92 208 96 85
Other Noncurrent Operating Assets
3,348 1,712 1,135 748 770 468 140 86 79 62
Total Liabilities & Shareholders' Equity
35,509 32,348 27,207 24,676 19,351 18,018 17,137 17,642 16,431 16,230
Total Liabilities
18,606 15,451 12,630 11,343 10,164 9,111 8,143 7,305 5,958 6,284
Total Current Liabilities
3,643 3,320 2,985 2,569 2,390 2,123 2,474 2,258 2,264 2,555
Short-Term Debt
750 599 500 500 550 500 749 500 631 1,000
Accounts Payable
820 802 851 571 415 388 478 466 396 386
Current Deferred & Payable Income Tax Liabilities
159 172 189 121 134 46 103 128 83 95
Current Employee Benefit Liabilities
839 836 799 775 767 714 724 722 710 664
Other Current Liabilities
1,075 911 646 602 524 475 420 442 444 410
Total Noncurrent Liabilities
14,963 12,131 9,645 8,774 7,774 6,988 5,669 5,047 3,694 3,729
Long-Term Debt
12,846 10,624 8,235 7,241 6,248 5,303 4,319 3,577 2,978 3,120
Noncurrent Deferred & Payable Income Tax Liabilities
53 63 66 87 90 78 42 78 33 37
Noncurrent Employee Benefit Liabilities
110 108 118 79 131 93 118 89 129 196
Other Noncurrent Operating Liabilities
1,954 1,336 1,226 1,367 1,305 1,514 1,190 1,303 554 -
Total Equity & Noncontrolling Interests
16,903 16,897 14,577 13,333 9,187 8,907 8,994 10,337 10,473 9,946
Total Preferred & Common Equity
16,903 16,897 14,577 13,333 9,187 8,907 8,994 10,337 10,473 9,946
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
16,903 16,897 14,577 13,333 9,187 8,907 8,994 10,337 10,473 9,946
Common Stock
5,676 5,103 4,692 4,371 4,074 3,851 3,691 3,517 3,415 3,370
Retained Earnings
52,262 52,283 50,353 45,919 42,051 39,898 37,906 34,662 33,107 31,176
Treasury Stock
-40,895 -40,284 -40,214 -36,800 -36,578 -34,495 -32,130 -27,458 -25,523 -24,068
Accumulated Other Comprehensive Income / (Loss)
-140 -205 -254 -157 -360 -347 -473 -384 -526 -532

Quarterly Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
33,757 35,509 35,321 35,048 34,885 32,348 31,638 30,939 29,220 27,207 26,057
Total Current Assets
13,086 15,026 15,872 16,789 17,448 15,122 15,097 15,514 15,023 14,021 13,772
Cash & Equivalents
2,763 3,200 2,589 2,740 2,483 2,964 2,566 3,439 4,477 3,050 3,169
Short-Term Investments
2,242 4,380 6,163 6,948 7,910 5,611 6,382 6,113 5,068 6,017 5,921
Accounts Receivable
1,860 1,719 1,862 1,711 1,671 1,787 1,976 1,956 1,877 1,895 2,040
Inventories, net
4,687 4,527 4,296 4,106 4,083 3,999 3,908 3,729 3,288 2,757 2,404
Prepaid Expenses
1,534 1,200 962 1,284 1,301 761 265 277 313 302 238
Plant, Property, & Equipment, net
11,811 11,347 11,802 11,174 10,442 9,999 9,320 8,525 7,665 6,876 6,485
Plant, Property & Equipment, gross
16,036 15,254 15,464 14,622 13,739 13,268 12,528 11,664 10,791 9,950 9,491
Accumulated Depreciation
4,225 3,907 3,662 3,448 3,297 3,269 3,208 3,139 3,126 3,074 3,006
Total Noncurrent Assets
8,860 9,136 7,647 7,085 6,995 7,227 7,221 6,900 6,532 6,310 5,800
Goodwill
4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362
Intangible Assets
263 257 229 230 231 223 138 143 140 152 75
Noncurrent Deferred & Refundable Income Taxes
1,030 936 941 905 821 757 632 537 486 473 291
Employee Benefit Assets
240 233 184 167 169 173 166 183 189 188 273
Other Noncurrent Operating Assets
2,965 3,348 1,931 1,421 1,412 1,712 1,923 1,675 1,355 1,135 799
Total Liabilities & Shareholders' Equity
33,757 35,509 35,321 35,048 34,885 32,348 31,638 30,939 29,220 27,207 26,057
Total Liabilities
17,351 18,606 18,053 17,834 17,902 15,451 15,007 14,999 13,977 12,630 11,550
Total Current Liabilities
2,489 3,643 3,686 3,637 3,553 3,320 2,652 2,711 2,904 2,985 2,798
Short-Term Debt
0.00 750 1,049 1,049 1,349 599 300 299 500 500 499
Accounts Payable
866 820 794 858 551 802 713 923 952 851 780
Current Deferred & Payable Income Tax Liabilities
284 159 108 178 378 172 108 121 372 189 123
Current Employee Benefit Liabilities
418 839 721 569 399 836 707 561 394 799 662
Other Current Liabilities
921 1,075 1,014 983 876 911 824 807 686 646 734
Total Noncurrent Liabilities
14,862 14,963 14,367 14,197 14,349 12,131 12,355 12,288 11,073 9,645 8,752
Long-Term Debt
12,848 12,846 12,844 12,842 12,840 10,624 10,922 10,920 9,626 8,235 7,438
Noncurrent Deferred & Payable Income Tax Liabilities
56 53 54 55 55 63 66 69 73 66 92
Noncurrent Employee Benefit Liabilities
115 110 117 113 111 108 141 127 123 118 69
Other Noncurrent Operating Liabilities
1,843 1,954 1,352 1,187 1,343 1,336 1,226 1,172 1,251 1,226 1,153
Total Equity & Noncontrolling Interests
16,406 16,903 17,268 17,214 16,983 16,897 16,631 15,940 15,243 14,577 14,507
Total Preferred & Common Equity
16,406 16,903 17,268 17,214 16,983 16,897 16,631 15,940 15,243 14,577 14,507
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
16,406 16,903 17,268 17,214 16,983 16,897 16,631 15,940 15,243 14,577 14,507
Common Stock
5,799 5,676 5,554 5,407 5,180 5,103 5,021 4,904 4,757 4,692 4,618
Retained Earnings
52,196 52,262 52,304 52,135 52,199 52,283 52,098 51,522 50,930 50,353 49,519
Treasury Stock
-41,442 -40,895 -40,395 -40,128 -40,193 -40,284 -40,253 -40,240 -40,192 -40,214 -39,476
Accumulated Other Comprehensive Income / (Loss)
-147 -140 -195 -200 -203 -205 -235 -246 -252 -254 -154

Annual Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
-10.72% -12.53% 9.18% 26.85% 0.54% -8.88% 5.50% 11.90% 2.85% -0.35%
EBITDA Growth
-16.29% -19.74% 11.61% 39.70% 3.61% -10.52% 9.95% 18.39% 9.67% 4.64%
EBIT Growth
-23.29% -24.16% 12.56% 46.66% 5.24% -13.40% 10.60% 22.91% 16.35% 8.52%
NOPAT Growth
-25.24% -27.25% 13.31% 42.41% 9.34% -10.53% 52.09% 4.05% 15.66% 6.50%
Net Income Growth
-26.28% -25.59% 12.61% 38.86% 11.52% -10.09% 51.55% 2.42% 20.40% 5.85%
EPS Growth
-26.45% -24.87% 13.92% 38.36% 13.93% -6.26% 54.85% 3.74% 23.40% 9.73%
Operating Cash Flow Growth
-1.59% -26.38% -0.41% 42.63% -7.67% -7.51% 34.05% 16.23% 4.94% 8.46%
Free Cash Flow Firm Growth
26.63% -80.89% 0.79% 15.73% -8.64% -2.35% 30.65% 14.53% 3.26% 4.29%
Invested Capital Growth
17.26% 37.21% 25.67% 20.37% 4.37% -5.79% -1.02% -6.57% -2.54% -5.59%
Revenue Q/Q Growth
-0.45% -3.27% -0.80% 4.30% 5.29% -2.49% -0.21% 2.30% 1.71% -0.61%
EBITDA Q/Q Growth
-0.78% -5.33% -2.05% 5.31% 10.19% -3.29% -0.09% 0.74% 5.69% 0.15%
EBIT Q/Q Growth
-2.57% -6.96% -2.71% 6.27% 12.16% -3.86% -0.47% 0.90% 7.63% 1.22%
NOPAT Q/Q Growth
-2.77% -8.68% -2.23% 8.09% 10.47% -3.60% 19.11% -13.48% 1.49% 1.24%
Net Income Q/Q Growth
-3.34% -8.32% -1.97% 6.15% 12.42% -3.26% 19.10% -16.03% 6.24% 0.37%
EPS Q/Q Growth
-3.53% -8.30% -1.36% 6.03% 12.64% -2.42% 19.44% -15.65% 6.75% 1.81%
Operating Cash Flow Q/Q Growth
1.19% -1.80% -3.49% 2.72% 6.43% -5.55% 3.10% 11.24% -3.59% 2.93%
Free Cash Flow Firm Q/Q Growth
-0.48% -24.14% 2.31% -11.73% 5.42% -6.75% 5.96% 11.44% -7.35% 2.97%
Invested Capital Q/Q Growth
2.28% 3.39% 6.67% 12.14% -1.46% -4.22% -6.02% -10.97% -1.61% -4.70%
Profitability Metrics
- - - - - - - - - -
Gross Margin
58.14% 62.90% 68.76% 67.47% 64.10% 63.71% 65.11% 64.26% 61.76% 58.27%
EBITDA Margin
48.21% 51.42% 56.05% 54.82% 49.78% 48.31% 49.20% 47.20% 44.61% 41.84%
Operating Margin
34.94% 41.85% 50.63% 48.84% 40.76% 39.79% 42.53% 40.66% 36.31% 33.25%
EBIT Margin
38.11% 44.36% 51.16% 49.62% 42.92% 41.01% 43.15% 41.16% 37.47% 33.12%
Profit (Net Income) Margin
30.68% 37.16% 43.68% 42.35% 38.69% 34.88% 35.35% 24.61% 26.89% 22.97%
Tax Burden Percent
88.01% 87.76% 87.21% 87.11% 92.99% 87.59% 83.46% 60.56% 72.92% 70.83%
Interest Burden Percent
91.48% 95.46% 97.91% 97.98% 96.94% 97.12% 98.16% 98.73% 98.40% 97.91%
Effective Tax Rate
11.99% 12.24% 12.79% 12.89% 7.01% 12.41% 16.54% 39.44% 27.08% 29.17%
Return on Invested Capital (ROIC)
22.65% 38.08% 69.14% 75.22% 59.44% 53.90% 58.19% 36.78% 33.74% 27.98%
ROIC Less NNEP Spread (ROIC-NNEP)
22.41% 44.67% 77.23% 79.26% 125.55% 55.15% 117.49% 37.24% 53.10% 18.27%
Return on Net Nonoperating Assets (RNNOA)
5.74% 3.29% -6.45% -6.22% 2.40% 2.16% -0.46% -1.39% 1.47% 1.39%
Return on Equity (ROE)
28.40% 41.37% 62.69% 69.00% 61.84% 56.05% 57.73% 35.39% 35.21% 29.37%
Cash Return on Invested Capital (CROIC)
6.76% 6.71% 46.39% 56.73% 55.17% 59.86% 59.22% 43.56% 36.32% 33.73%
Operating Return on Assets (OROA)
17.57% 26.10% 39.50% 41.35% 33.22% 33.55% 39.17% 36.15% 30.68% 25.63%
Return on Assets (ROA)
14.14% 21.86% 33.73% 35.29% 29.94% 28.54% 32.09% 21.61% 22.01% 17.77%
Return on Common Equity (ROCE)
28.40% 41.37% 62.69% 69.00% 61.84% 56.05% 57.73% 35.39% 35.21% 29.37%
Return on Equity Simple (ROE_SIMPLE)
28.39% 38.53% 60.02% 58.27% 60.90% 56.33% 62.04% 35.62% 34.33% 30.02%
Net Operating Profit after Tax (NOPAT)
4,810 6,434 8,843 7,805 5,481 5,013 5,603 3,684 3,540 3,061
NOPAT Margin
30.75% 36.72% 44.15% 42.55% 37.90% 34.85% 35.50% 24.62% 26.48% 23.55%
Net Nonoperating Expense Percent (NNEP)
0.24% -6.59% -8.08% -4.04% -66.11% -1.25% -59.30% -0.47% -19.36% 9.71%
Return On Investment Capital (ROIC_SIMPLE)
15.77% 22.88% 37.93% - - - - - - -
Cost of Revenue to Revenue
41.86% 37.10% 31.24% 32.53% 35.90% 36.29% 34.89% 35.74% 38.24% 41.73%
SG&A Expenses to Revenue
11.47% 10.42% 8.51% 9.38% 11.39% 11.44% 10.67% 11.32% 13.03% 13.29%
R&D to Revenue
12.52% 10.63% 8.34% 8.47% 10.58% 10.73% 9.88% 10.08% 10.14% 9.75%
Operating Expenses to Revenue
23.20% 21.05% 18.13% 18.62% 23.34% 23.92% 22.58% 23.60% 25.45% 25.02%
Earnings before Interest and Taxes (EBIT)
5,961 7,771 10,246 9,103 6,207 5,898 6,811 6,158 5,010 4,306
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7,541 9,009 11,225 10,057 7,199 6,948 7,765 7,062 5,965 5,439
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
10.05 8.84 9.63 12.05 14.79 11.79 8.60 8.27 5.64 4.41
Price to Tangible Book Value (P/TBV)
13.82 12.14 13.94 18.08 28.88 25.40 19.75 17.38 12.32 11.09
Price to Revenue (P/Rev)
10.86 8.53 7.01 8.76 9.39 7.30 4.90 5.71 4.42 3.37
Price to Earnings (P/E)
35.56 23.07 16.11 20.76 24.40 21.07 13.96 23.42 16.63 14.90
Dividend Yield
2.83% 3.05% 3.03% 2.42% 2.51% 2.86% 3.27% 2.44% 2.77% 3.24%
Earnings Yield
2.81% 4.33% 6.21% 4.82% 4.10% 4.75% 7.16% 4.27% 6.01% 6.71%
Enterprise Value to Invested Capital (EV/IC)
7.67 7.78 9.83 13.99 14.45 11.65 8.14 8.76 5.69 4.19
Enterprise Value to Revenue (EV/Rev)
11.24 8.68 6.99 8.65 9.41 7.31 4.94 5.67 4.41 3.43
Enterprise Value to EBITDA (EV/EBITDA)
23.31 16.88 12.47 15.77 18.90 15.13 10.03 12.01 9.88 8.19
Enterprise Value to EBIT (EV/EBIT)
29.49 19.57 13.66 17.43 21.92 17.83 11.44 13.77 11.77 10.34
Enterprise Value to NOPAT (EV/NOPAT)
36.55 23.64 15.83 20.32 24.83 20.98 13.91 23.02 16.65 14.55
Enterprise Value to Operating Cash Flow (EV/OCF)
27.83 23.69 16.05 18.12 22.16 15.81 10.84 15.82 12.78 10.13
Enterprise Value to Free Cash Flow (EV/FCFF)
122.47 134.14 23.59 26.95 26.75 18.89 13.67 19.44 15.47 12.07
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.80 0.66 0.60 0.58 0.74 0.65 0.56 0.39 0.34 0.41
Long-Term Debt to Equity
0.76 0.63 0.56 0.54 0.68 0.60 0.48 0.35 0.28 0.31
Financial Leverage
0.26 0.07 -0.08 -0.08 0.02 0.04 0.00 -0.04 0.03 0.08
Leverage Ratio
2.01 1.89 1.86 1.96 2.07 1.96 1.80 1.64 1.60 1.65
Compound Leverage Factor
1.84 1.81 1.82 1.92 2.00 1.91 1.77 1.62 1.57 1.62
Debt to Total Capital
44.58% 39.91% 37.47% 36.73% 42.53% 39.45% 36.04% 28.29% 25.63% 29.29%
Short-Term Debt to Total Capital
2.46% 2.13% 2.14% 2.37% 3.44% 3.40% 5.33% 3.47% 4.48% 7.11%
Long-Term Debt to Total Capital
42.12% 37.78% 35.33% 34.36% 39.09% 36.05% 30.71% 24.82% 21.15% 22.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
55.42% 60.09% 62.53% 63.27% 57.47% 60.55% 63.96% 71.72% 74.37% 70.71%
Debt to EBITDA
1.80 1.25 0.78 0.77 0.94 0.84 0.65 0.58 0.61 0.76
Net Debt to EBITDA
0.80 0.29 -0.03 -0.20 0.03 0.02 0.08 -0.09 -0.02 0.13
Long-Term Debt to EBITDA
1.70 1.18 0.73 0.72 0.87 0.76 0.56 0.51 0.50 0.57
Debt to NOPAT
2.83 1.74 0.99 0.99 1.24 1.16 0.90 1.11 1.02 1.35
Net Debt to NOPAT
1.25 0.41 -0.04 -0.26 0.04 0.02 0.10 -0.18 -0.03 0.22
Long-Term Debt to NOPAT
2.67 1.65 0.93 0.93 1.14 1.06 0.77 0.97 0.84 1.02
Altman Z-Score
8.92 9.84 11.72 13.60 13.35 12.34 11.42 12.21 10.97 8.89
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
4.12 4.55 4.70 5.33 4.28 4.13 3.27 3.87 3.29 2.77
Quick Ratio
2.55 3.12 3.67 4.45 3.34 3.04 2.20 2.55 2.10 1.72
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,436 1,134 5,933 5,887 5,087 5,568 5,702 4,364 3,810 3,690
Operating Cash Flow to CapEx
136.61% 126.68% 312.10% 366.82% 951.78% 813.83% 640.73% 818.78% 868.93% 997.05%
Free Cash Flow to Firm to Interest Expense
2.83 3.21 27.73 31.99 26.77 32.75 45.61 55.95 47.63 41.00
Operating Cash Flow to Interest Expense
12.44 18.19 40.75 47.59 32.31 39.11 57.51 68.76 57.68 48.86
Operating Cash Flow Less CapEx to Interest Expense
3.33 3.83 27.69 34.61 28.92 34.31 48.54 60.36 51.04 43.96
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.46 0.59 0.77 0.83 0.77 0.82 0.91 0.88 0.82 0.77
Accounts Receivable Turnover
8.92 9.52 11.14 11.78 11.62 12.61 12.70 11.76 11.00 10.78
Inventory Turnover
1.54 1.92 2.68 3.09 2.62 2.47 2.64 2.85 2.94 3.12
Fixed Asset Turnover
1.47 2.08 3.33 4.36 4.40 4.44 5.40 5.78 5.23 4.78
Accounts Payable Turnover
8.07 7.86 8.80 12.11 12.93 12.05 11.67 12.41 13.08 13.18
Days Sales Outstanding (DSO)
40.91 38.36 32.77 30.99 31.40 28.94 28.73 31.04 33.20 33.85
Days Inventory Outstanding (DIO)
237.67 189.69 136.12 118.19 139.05 147.50 138.32 127.89 124.25 116.90
Days Payable Outstanding (DPO)
45.21 46.41 41.48 30.15 28.23 30.28 31.28 29.42 27.91 27.69
Cash Conversion Cycle (CCC)
233.36 181.63 127.42 119.03 142.23 146.16 135.77 129.51 129.53 123.06
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
22,919 19,545 14,245 11,335 9,417 9,023 9,578 9,677 10,357 10,627
Invested Capital Turnover
0.74 1.04 1.57 1.77 1.57 1.55 1.64 1.49 1.27 1.19
Increase / (Decrease) in Invested Capital
3,374 5,300 2,910 1,918 394 -555 -99 -680 -270 -629
Enterprise Value (EV)
175,810 152,067 139,990 158,627 136,070 105,150 77,917 84,816 58,954 44,534
Market Capitalization
169,794 149,419 140,322 160,625 135,840 105,034 77,333 85,476 59,070 43,853
Book Value per Share
$18.53 $18.60 $16.06 $14.44 $10.01 $9.53 $9.36 $10.49 $10.48 $9.80
Tangible Book Value per Share
$13.47 $13.56 $11.09 $9.62 $5.12 $4.42 $4.08 $4.99 $4.80 $3.90
Total Capital
30,499 28,120 23,312 21,074 15,985 14,710 14,062 14,414 14,082 14,066
Total Debt
13,596 11,223 8,735 7,741 6,798 5,803 5,068 4,077 3,609 4,120
Total Long-Term Debt
12,846 10,624 8,235 7,241 6,248 5,303 4,319 3,577 2,978 3,120
Net Debt
6,016 2,648 -332 -1,998 230 116 584 -660 -116 681
Capital Expenditures (CapEx)
4,625 5,068 2,794 2,387 645 817 1,122 655 531 441
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4,553 3,826 2,469 1,877 1,831 1,751 2,139 2,507 2,334 2,301
Debt-free Net Working Capital (DFNWC)
12,133 12,401 11,536 11,616 8,399 7,138 6,372 6,976 5,824 5,519
Net Working Capital (NWC)
11,383 11,802 11,036 11,116 7,849 6,638 5,623 6,476 5,193 4,519
Net Nonoperating Expense (NNE)
11 -76 94 36 -114 -4.38 23 1.82 -55 75
Net Nonoperating Obligations (NNO)
6,016 2,648 -332 -1,998 230 116 584 -660 -116 681
Total Depreciation and Amortization (D&A)
1,580 1,238 979 954 992 1,050 954 904 955 1,133
Debt-free, Cash-free Net Working Capital to Revenue
29.11% 21.84% 12.33% 10.23% 12.66% 12.17% 13.55% 16.76% 17.46% 17.70%
Debt-free Net Working Capital to Revenue
77.57% 70.79% 57.60% 63.32% 58.08% 49.63% 40.37% 46.63% 43.56% 42.45%
Net Working Capital to Revenue
72.78% 67.37% 55.10% 60.60% 54.28% 46.15% 35.62% 43.29% 38.84% 34.76%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$5.24 $7.13 $9.51 $8.38 $6.05 $5.33 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
912M 908M 916M 923M 921M 936M 0.00 0.00 0.00 0.00
Adjusted Diluted Earnings per Share
$5.20 $7.07 $9.41 $8.26 $5.97 $5.24 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
919M 916M 926M 936M 933M 952M 0.00 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
910.33M 909.29M 906.21M 923.55M 920.24M 933.98M 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
4,700 6,434 9,067 7,805 5,481 4,981 5,870 3,883 3,762 3,244
Normalized NOPAT Margin
30.05% 36.72% 45.27% 42.55% 37.90% 34.63% 37.19% 25.95% 28.14% 24.95%
Pre Tax Income Margin
34.86% 42.34% 50.09% 48.62% 41.61% 39.82% 42.36% 40.64% 36.87% 32.43%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
11.73 22.01 47.88 49.47 32.67 34.69 54.49 78.95 62.63 47.84
NOPAT to Interest Expense
9.47 18.23 41.32 42.42 28.85 29.49 44.82 47.23 44.25 34.01
EBIT Less CapEx to Interest Expense
2.63 7.66 34.82 36.50 29.27 29.89 45.51 70.55 55.99 42.94
NOPAT Less CapEx to Interest Expense
0.36 3.87 28.27 29.44 25.45 24.68 35.84 38.83 37.62 29.11
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
99.92% 70.00% 49.11% 50.02% 61.23% 59.96% 45.79% 57.14% 45.79% 48.36%
Augmented Payout Ratio
119.27% 74.50% 90.43% 56.80% 106.86% 118.96% 137.19% 126.56% 105.09% 140.15%

Quarterly Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.14% -1.72% -8.41% -15.65% -16.40% -12.70% -13.53% -13.07% -10.72% -3.35% 12.88%
EBITDA Growth
4.35% -2.98% -10.81% -26.43% -22.83% -20.36% -21.29% -19.49% -17.80% -8.62% 15.55%
EBIT Growth
-0.35% -9.54% -16.58% -34.10% -30.04% -26.09% -25.49% -23.41% -21.88% -11.35% 16.85%
NOPAT Growth
11.31% -10.07% -19.04% -33.50% -35.26% -31.09% -27.24% -27.10% -23.99% -9.32% 17.21%
Net Income Growth
6.70% -12.11% -20.30% -34.55% -35.30% -30.12% -25.53% -24.84% -22.40% -8.23% 17.87%
EPS Growth
6.67% -12.67% -20.54% -34.76% -35.14% -29.91% -25.10% -23.67% -21.28% -5.73% 19.32%
Operating Cash Flow Growth
-16.52% 3.85% -10.58% 12.29% -12.33% -5.78% -29.97% -20.87% -45.90% -13.36% 13.92%
Free Cash Flow Firm Growth
41.74% 45.39% 44.63% 9.44% -75.87% -319.46% -314.32% -387.05% -7,598.53% -468.97% -165.68%
Invested Capital Growth
16.70% 17.26% 18.53% 21.64% 31.31% 37.21% 41.57% 35.97% 32.60% 25.67% 32.11%
Revenue Q/Q Growth
1.55% -3.47% 8.61% 4.40% -10.20% -10.04% 0.02% 3.47% -6.23% -10.89% 0.56%
EBITDA Q/Q Growth
-3.95% -7.81% 18.65% -0.68% -10.69% -15.26% -2.13% 4.18% -7.83% -16.25% 0.10%
EBIT Q/Q Growth
-5.71% -11.63% 22.28% -2.20% -14.40% -18.51% -3.40% 3.82% -9.56% -17.85% -0.70%
NOPAT Q/Q Growth
0.20% -10.36% 20.76% 2.63% -19.05% -19.30% -0.82% -0.07% -13.84% -14.80% -0.63%
Net Income Q/Q Growth
-2.16% -11.53% 20.85% 1.99% -19.40% -19.78% -0.75% 0.82% -12.95% -14.51% 0.17%
EPS Q/Q Growth
-2.29% -10.88% 20.49% 1.67% -20.00% -18.92% -1.07% 1.08% -13.55% -13.36% 0.82%
Operating Cash Flow Q/Q Growth
-57.51% 15.36% 10.25% 54.47% -47.14% -0.67% 38.46% 20.60% -43.19% -26.18% 56.45%
Free Cash Flow Firm Q/Q Growth
-4.35% -0.52% 20.14% 30.44% 2.19% -1.90% -30.62% -35.09% -133.29% -0.66% -53.55%
Invested Capital Q/Q Growth
5.80% 2.28% 4.63% 3.07% 6.31% 3.39% 7.37% 11.27% 11.08% 6.67% 3.13%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
56.84% 57.75% 59.60% 57.85% 57.22% 59.63% 62.11% 64.22% 65.38% 66.10% 69.01%
EBITDA Margin
45.42% 48.02% 50.28% 46.02% 48.37% 48.64% 51.63% 52.77% 52.41% 53.32% 56.73%
Operating Margin
32.54% 34.36% 37.44% 32.65% 35.13% 37.60% 41.75% 43.52% 44.17% 46.60% 51.10%
EBIT Margin
34.50% 37.16% 40.59% 36.05% 38.49% 40.37% 44.57% 46.15% 45.99% 47.69% 51.73%
Profit (Net Income) Margin
28.98% 30.07% 32.81% 29.49% 30.18% 33.63% 37.71% 38.00% 39.00% 42.01% 43.79%
Tax Burden Percent
92.40% 88.67% 87.64% 90.38% 85.46% 88.57% 88.92% 86.01% 87.77% 90.54% 86.34%
Interest Burden Percent
90.88% 91.27% 92.23% 90.49% 91.77% 94.05% 95.15% 95.74% 96.62% 97.31% 98.05%
Effective Tax Rate
7.60% 11.33% 12.36% 9.62% 14.54% 11.43% 11.08% 13.99% 12.23% 9.46% 13.66%
Return on Invested Capital (ROIC)
21.43% 22.45% 24.96% 24.34% 27.56% 34.53% 41.68% 46.12% 54.47% 66.06% 75.93%
ROIC Less NNEP Spread (ROIC-NNEP)
20.67% 22.08% 24.96% 24.31% 27.83% 35.68% 46.44% 55.97% 53.07% 66.76% 77.01%
Return on Net Nonoperating Assets (RNNOA)
7.21% 5.66% 5.46% 4.30% 3.78% 2.63% 1.67% 0.98% -2.72% -5.57% -9.23%
Return on Equity (ROE)
28.64% 28.11% 30.41% 28.64% 31.34% 37.16% 43.36% 47.09% 51.74% 60.49% 66.70%
Cash Return on Invested Capital (CROIC)
6.50% 6.76% 6.98% 7.47% 4.81% 6.71% 9.26% 19.75% 31.83% 46.39% 49.43%
Operating Return on Assets (OROA)
16.13% 17.13% 19.05% 17.58% 20.17% 23.75% 27.98% 31.21% 32.92% 36.82% 42.34%
Return on Assets (ROA)
13.55% 13.86% 15.40% 14.38% 15.82% 19.78% 23.68% 25.70% 27.92% 32.44% 35.84%
Return on Common Equity (ROCE)
28.64% 28.11% 30.41% 28.64% 31.34% 37.16% 43.36% 47.09% 51.74% 60.49% 66.70%
Return on Equity Simple (ROE_SIMPLE)
29.70% 0.00% 28.75% 30.86% 34.78% 0.00% 42.70% 48.22% 54.16% 0.00% 61.52%
Net Operating Profit after Tax (NOPAT)
1,223 1,221 1,362 1,128 1,099 1,358 1,682 1,696 1,697 1,970 2,312
NOPAT Margin
30.07% 30.47% 32.81% 29.51% 30.02% 33.30% 37.12% 37.44% 38.76% 42.19% 44.12%
Net Nonoperating Expense Percent (NNEP)
0.76% 0.37% 0.00% 0.03% -0.27% -1.15% -4.76% -9.85% 1.40% -0.70% -1.08%
Return On Investment Capital (ROIC_SIMPLE)
4.18% 4.00% - - - 4.83% - - - 8.45% -
Cost of Revenue to Revenue
43.16% 42.25% 40.40% 42.15% 42.78% 40.37% 37.89% 35.78% 34.62% 33.90% 30.99%
SG&A Expenses to Revenue
11.60% 11.13% 10.31% 12.17% 12.43% 10.74% 9.97% 10.17% 10.82% 4.71% 9.69%
R&D to Revenue
12.71% 12.25% 11.85% 13.03% 13.06% 11.28% 10.39% 10.53% 10.39% 9.29% 8.22%
Operating Expenses to Revenue
24.31% 23.38% 22.16% 25.20% 22.10% 22.03% 20.37% 20.70% 21.21% 19.51% 17.92%
Earnings before Interest and Taxes (EBIT)
1,404 1,489 1,685 1,378 1,409 1,646 2,020 2,091 2,014 2,227 2,711
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,848 1,924 2,087 1,759 1,771 1,983 2,340 2,391 2,295 2,490 2,973
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.97 10.05 10.92 10.22 9.19 8.84 8.42 9.87 10.57 9.63 9.18
Price to Tangible Book Value (P/TBV)
13.89 13.82 14.88 13.94 12.60 12.14 11.54 13.76 15.00 13.94 13.22
Price to Revenue (P/Rev)
10.19 10.86 12.00 10.94 9.29 8.53 7.73 8.36 8.26 7.01 6.59
Price to Earnings (P/E)
33.74 35.56 38.17 33.30 26.55 23.07 19.82 20.57 19.60 16.11 14.98
Dividend Yield
2.96% 2.83% 2.52% 2.66% 2.96% 3.05% 3.22% 2.81% 2.69% 3.03% 3.16%
Earnings Yield
2.96% 2.81% 2.62% 3.00% 3.77% 4.33% 5.05% 4.86% 5.10% 6.21% 6.67%
Enterprise Value to Invested Capital (EV/IC)
7.07 7.67 8.65 8.41 7.69 7.78 7.53 9.03 10.22 9.83 9.88
Enterprise Value to Revenue (EV/Rev)
10.68 11.24 12.33 11.20 9.52 8.68 7.86 8.45 8.29 6.99 6.54
Enterprise Value to EBITDA (EV/EBITDA)
22.50 23.31 25.49 22.94 18.84 16.88 14.95 15.67 15.07 12.47 11.52
Enterprise Value to EBIT (EV/EBIT)
28.78 29.49 31.67 27.92 22.31 19.57 17.04 17.59 16.70 13.66 12.53
Enterprise Value to NOPAT (EV/NOPAT)
34.75 36.55 39.17 34.21 27.40 23.64 20.20 20.72 19.46 15.83 14.59
Enterprise Value to Operating Cash Flow (EV/OCF)
27.87 27.83 31.03 27.94 25.47 23.69 21.76 21.59 20.90 16.05 14.61
Enterprise Value to Free Cash Flow (EV/FCFF)
117.17 122.47 134.31 123.67 181.58 134.14 95.22 52.70 36.60 23.59 22.76
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.78 0.80 0.80 0.81 0.84 0.66 0.67 0.70 0.66 0.60 0.55
Long-Term Debt to Equity
0.78 0.76 0.74 0.75 0.76 0.63 0.66 0.69 0.63 0.56 0.51
Financial Leverage
0.35 0.26 0.22 0.18 0.14 0.07 0.04 0.02 -0.05 -0.08 -0.12
Leverage Ratio
2.06 2.01 1.98 1.99 1.99 1.89 1.85 1.85 1.86 1.86 1.85
Compound Leverage Factor
1.87 1.83 1.82 1.80 1.83 1.78 1.76 1.77 1.80 1.81 1.81
Debt to Total Capital
43.92% 44.58% 44.58% 44.66% 45.52% 39.91% 40.29% 41.31% 39.91% 37.47% 35.36%
Short-Term Debt to Total Capital
0.00% 2.46% 3.37% 3.37% 4.33% 2.13% 1.08% 1.10% 1.97% 2.14% 2.22%
Long-Term Debt to Total Capital
43.92% 42.12% 41.22% 41.29% 41.19% 37.78% 39.21% 40.21% 37.94% 35.33% 33.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
56.08% 55.42% 55.42% 55.34% 54.48% 60.09% 59.71% 58.69% 60.09% 62.53% 64.64%
Debt to EBITDA
1.69 1.80 1.83 1.77 1.67 1.25 1.18 1.11 0.94 0.78 0.69
Net Debt to EBITDA
1.03 0.80 0.68 0.54 0.45 0.29 0.24 0.16 0.05 -0.03 -0.10
Long-Term Debt to EBITDA
1.69 1.70 1.69 1.64 1.51 1.18 1.15 1.08 0.90 0.73 0.65
Debt to NOPAT
2.60 2.83 2.81 2.64 2.43 1.74 1.59 1.46 1.22 0.99 0.88
Net Debt to NOPAT
1.59 1.25 1.04 0.80 0.65 0.41 0.32 0.22 0.07 -0.04 -0.13
Long-Term Debt to NOPAT
2.60 2.67 2.60 2.44 2.20 1.65 1.55 1.42 1.16 0.93 0.82
Altman Z-Score
8.81 8.50 9.36 9.04 8.42 9.21 9.16 9.95 10.75 10.75 11.20
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.26 4.12 4.31 4.62 4.91 4.55 5.69 5.72 5.17 4.70 4.92
Quick Ratio
2.76 2.55 2.88 3.13 3.40 3.12 4.12 4.24 3.93 3.67 3.98
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2,247 -2,153 -2,142 -2,682 -3,856 -3,942 -3,869 -2,962 -2,193 -940 -934
Operating Cash Flow to CapEx
75.60% 167.76% 131.61% 147.93% 96.31% 167.60% 129.65% 96.82% 118.25% 211.17% 350.13%
Free Cash Flow to Firm to Interest Expense
-17.55 -16.56 -16.35 -20.47 -33.24 -40.23 -39.48 -33.28 -32.24 -15.66 -17.62
Operating Cash Flow to Interest Expense
6.63 15.37 13.22 11.99 8.77 19.63 19.77 15.72 17.06 34.03 52.19
Operating Cash Flow Less CapEx to Interest Expense
-2.14 6.21 3.18 3.89 -0.34 7.92 4.52 -0.52 2.63 17.92 37.28
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.47 0.46 0.47 0.49 0.52 0.59 0.63 0.68 0.72 0.77 0.82
Accounts Receivable Turnover
9.09 8.92 8.19 8.78 9.47 9.52 9.02 9.08 10.62 11.14 10.93
Inventory Turnover
1.54 1.54 1.58 1.67 1.78 1.92 2.04 2.14 2.36 2.68 2.89
Fixed Asset Turnover
1.44 1.47 1.49 1.63 1.86 2.08 2.29 2.60 2.98 3.33 3.84
Accounts Payable Turnover
9.51 8.07 8.63 7.34 8.72 7.86 8.62 7.76 7.92 8.80 8.95
Days Sales Outstanding (DSO)
40.15 40.91 44.58 41.59 38.54 38.36 40.47 40.20 34.36 32.77 33.38
Days Inventory Outstanding (DIO)
237.57 237.67 230.34 218.64 205.38 189.69 178.96 170.53 154.68 136.12 126.50
Days Payable Outstanding (DPO)
38.39 45.21 42.31 49.70 41.88 46.41 42.33 47.03 46.07 41.48 40.79
Cash Conversion Cycle (CCC)
239.34 233.36 232.61 210.53 202.04 181.63 177.09 163.70 142.97 127.42 119.09
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
24,249 22,919 22,409 21,417 20,779 19,545 18,905 17,607 15,824 14,245 13,354
Invested Capital Turnover
0.71 0.74 0.76 0.82 0.92 1.04 1.12 1.23 1.41 1.57 1.72
Increase / (Decrease) in Invested Capital
3,470 3,374 3,504 3,810 4,955 5,300 5,551 4,658 3,890 2,910 3,246
Enterprise Value (EV)
171,430 175,810 193,749 180,174 159,866 152,067 142,291 159,024 161,674 139,990 131,986
Market Capitalization
163,587 169,794 188,608 175,971 156,070 149,419 140,017 157,357 161,093 140,322 133,139
Book Value per Share
$18.02 $18.53 $18.91 $18.91 $18.66 $18.60 $18.32 $17.56 $16.82 $16.06 $15.88
Tangible Book Value per Share
$12.94 $13.47 $13.88 $13.86 $13.62 $13.56 $13.36 $12.60 $11.85 $11.09 $11.02
Total Capital
29,254 30,499 31,161 31,105 31,172 28,120 27,853 27,159 25,369 23,312 22,444
Total Debt
12,848 13,596 13,893 13,891 14,189 11,223 11,222 11,219 10,126 8,735 7,937
Total Long-Term Debt
12,848 12,846 12,844 12,842 12,840 10,624 10,922 10,920 9,626 8,235 7,438
Net Debt
7,843 6,016 5,141 4,203 3,796 2,648 2,274 1,667 581 -332 -1,153
Capital Expenditures (CapEx)
1,123 1,191 1,316 1,062 1,056 1,148 1,494 1,445 981 967 790
Debt-free, Cash-free Net Working Capital (DFCFNWC)
5,592 4,553 4,483 4,513 4,851 3,826 3,797 3,550 3,074 2,469 2,383
Debt-free Net Working Capital (DFNWC)
10,597 12,133 13,235 14,201 15,244 12,401 12,745 13,102 12,619 11,536 11,473
Net Working Capital (NWC)
10,597 11,383 12,186 13,152 13,895 11,802 12,445 12,803 12,119 11,036 10,974
Net Nonoperating Expense (NNE)
44 16 0.00 0.90 -5.98 -13 -27 -26 -11 8.15 17
Net Nonoperating Obligations (NNO)
7,843 6,016 5,141 4,203 3,796 2,648 2,274 1,667 581 -332 -1,153
Total Depreciation and Amortization (D&A)
444 435 402 381 362 337 320 300 281 263 262
Debt-free, Cash-free Net Working Capital to Revenue
34.84% 29.11% 28.53% 28.05% 28.87% 21.84% 20.96% 18.86% 15.76% 12.33% 11.80%
Debt-free Net Working Capital to Revenue
66.03% 77.57% 84.24% 88.25% 90.73% 70.79% 70.37% 69.61% 64.71% 57.60% 56.83%
Net Working Capital to Revenue
66.03% 72.78% 77.56% 81.73% 82.70% 67.37% 68.71% 68.03% 62.14% 55.10% 54.35%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.29 $1.32 $1.48 $1.23 $1.21 $1.50 $1.87 $1.89 $1.87 $2.16 $2.50
Adjusted Weighted Average Basic Shares Outstanding
910M 912M 913M 912M 910M 908M 908M 908M 907M 916M 913M
Adjusted Diluted Earnings per Share
$1.28 $1.31 $1.47 $1.22 $1.20 $1.50 $1.85 $1.87 $1.85 $2.14 $2.47
Adjusted Weighted Average Diluted Shares Outstanding
916M 919M 920M 919M 917M 916M 916M 916M 916M 926M 923M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
908.47M 910.33M 912.22M 913.05M 910.48M 909.29M 908.20M 907.97M 907.65M 906.21M 907.57M
Normalized Net Operating Profit after Tax (NOPAT)
1,223 1,221 1,362 1,128 993 1,358 1,682 1,696 1,697 1,970 2,312
Normalized NOPAT Margin
30.07% 30.47% 32.81% 29.51% 27.13% 33.30% 37.12% 37.44% 38.76% 42.19% 44.12%
Pre Tax Income Margin
31.36% 33.92% 37.44% 32.63% 35.32% 37.97% 42.41% 44.18% 44.44% 46.40% 50.72%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.97 11.45 12.86 10.52 12.15 16.80 20.61 23.49 29.62 37.12 51.15
NOPAT to Interest Expense
9.56 9.39 10.40 8.61 9.47 13.85 17.17 19.06 24.96 32.84 43.63
EBIT Less CapEx to Interest Expense
2.20 2.29 2.82 2.41 3.04 5.08 5.37 7.26 15.19 21.00 36.25
NOPAT Less CapEx to Interest Expense
0.78 0.23 0.35 0.50 0.37 2.14 1.92 2.82 10.54 16.72 28.72
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
99.53% 99.92% 95.39% 88.01% 78.13% 70.00% 63.36% 57.55% 52.80% 49.11% 47.46%
Augmented Payout Ratio
131.93% 119.27% 104.59% 91.49% 81.40% 74.50% 78.51% 83.91% 90.70% 90.43% 80.06%

Frequently Asked Questions About Texas Instruments' Financials

When does Texas Instruments's financial year end?

According to the most recent income statement we have on file, Texas Instruments' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Texas Instruments' net income changed over the last 9 years?

Texas Instruments' net income appears to be on an upward trend, with a most recent value of $4.80 billion in 2024, rising from $2.99 billion in 2015. The previous period was $6.51 billion in 2023. Check out Texas Instruments' forecast to explore projected trends and price targets.

What is Texas Instruments's operating income?
Texas Instruments's total operating income in 2024 was $5.47 billion, based on the following breakdown:
  • Total Gross Profit: $9.09 billion
  • Total Operating Expenses: $3.63 billion
How has Texas Instruments revenue changed over the last 9 years?

Over the last 9 years, Texas Instruments' total revenue changed from $13 billion in 2015 to $15.64 billion in 2024, a change of 20.3%.

How much debt does Texas Instruments have?

Texas Instruments' total liabilities were at $18.61 billion at the end of 2024, a 20.4% increase from 2023, and a 196.1% increase since 2015.

How much cash does Texas Instruments have?

In the past 9 years, Texas Instruments' cash and equivalents has ranged from $1 billion in 2015 to $4.63 billion in 2021, and is currently $3.20 billion as of their latest financial filing in 2024.

How has Texas Instruments' book value per share changed over the last 9 years?

Over the last 9 years, Texas Instruments' book value per share changed from 9.80 in 2015 to 18.53 in 2024, a change of 89.0%.



This page (NASDAQ:TXN) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners